JP4891763B2 - 「ｃｅｓｔ」用途のための、磁気共鳴シフト試薬と交換性プロトンを含有する基質との付加物 - Google Patents

「ｃｅｓｔ」用途のための、磁気共鳴シフト試薬と交換性プロトンを含有する基質との付加物 Download PDF

Info

Publication number
JP4891763B2
JP4891763B2 JP2006505027A JP2006505027A JP4891763B2 JP 4891763 B2 JP4891763 B2 JP 4891763B2 JP 2006505027 A JP2006505027 A JP 2006505027A JP 2006505027 A JP2006505027 A JP 2006505027A JP 4891763 B2 JP4891763 B2 JP 4891763B2
Authority
JP
Japan
Prior art keywords
iii
paramagnetic
cest
polysaccharides
substrate molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006505027A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006522761A5 (https=
JP2006522761A (ja
Inventor
アイメ，シルヴィオ
テッレノ，エンツォ
デッリ・カステッリ，ダニエーラ
ジョヴェンツァーナ，ジョヴァンニ・バッティスタ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco Imaging SpA
Original Assignee
Bracco Imaging SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging SpA filed Critical Bracco Imaging SpA
Publication of JP2006522761A publication Critical patent/JP2006522761A/ja
Publication of JP2006522761A5 publication Critical patent/JP2006522761A5/ja
Application granted granted Critical
Publication of JP4891763B2 publication Critical patent/JP4891763B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/146—Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Cephalosporin Compounds (AREA)
  • Compounds Of Iron (AREA)
  • Soft Magnetic Materials (AREA)
JP2006505027A 2003-04-11 2004-04-06 「ｃｅｓｔ」用途のための、磁気共鳴シフト試薬と交換性プロトンを含有する基質との付加物 Expired - Fee Related JP4891763B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03008456.0 2003-04-11
EP03008456A EP1466629A1 (en) 2003-04-11 2003-04-11 Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications
PCT/EP2004/003684 WO2004089424A1 (en) 2003-04-11 2004-04-06 Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for “cest” applications

Publications (3)

Publication Number Publication Date
JP2006522761A JP2006522761A (ja) 2006-10-05
JP2006522761A5 JP2006522761A5 (https=) 2007-05-24
JP4891763B2 true JP4891763B2 (ja) 2012-03-07

Family

ID=32865006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505027A Expired - Fee Related JP4891763B2 (ja) 2003-04-11 2004-04-06 「ｃｅｓｔ」用途のための、磁気共鳴シフト試薬と交換性プロトンを含有する基質との付加物

Country Status (9)

Country Link
US (1) US8945512B2 (https=)
EP (3) EP1466629A1 (https=)
JP (1) JP4891763B2 (https=)
CN (1) CN100579583C (https=)
AT (1) ATE444763T1 (https=)
AU (1) AU2004228932B2 (https=)
DE (1) DE602004023492D1 (https=)
WO (1) WO2004089424A1 (https=)
ZA (1) ZA200508155B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008513533A (ja) * 2004-09-23 2008-05-01 ゲルベ Ｃｅｓｔイメージング用の造影剤封入システム
WO2006086343A2 (en) * 2005-02-07 2006-08-17 The Johns Hopkins University Chemical exchange saturation transfer based mri using reporter genes and mri methods related thereto
JP5638752B2 (ja) * 2005-04-26 2014-12-10 コーニンクレッカ フィリップス エヌ ヴェ Ｃｅｓｔ活性な常磁性の錯体を含むｍｒｉ造影剤
EP1716870A1 (en) * 2005-04-29 2006-11-02 Bracco Imaging S.p.A. MRI contrast agents endowed with concentration independent responsiveness
EP1907873B1 (en) * 2005-07-21 2015-02-25 Johns Hopkins University Non-invasive mri measurement of tissue glycogen
DE102007039899B3 (de) * 2007-08-23 2009-04-09 Siemens Ag Sensor zum Ermöglichen des Nachweises einer Substanz im Körper eines Lebewesens
WO2011075476A1 (en) * 2009-12-14 2011-06-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Methods and compositions relating to reporter gels for use in mri techniques
EP2457594A1 (en) * 2010-11-05 2012-05-30 Bracco Imaging S.p.A Cest systems exhibiting a concentration independent responsiveness
CN109963839A (zh) * 2016-09-19 2019-07-02 香港理工大学 手性轮环藤宁化合物及其用途

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0597712A (ja) * 1991-10-04 1993-04-20 Nippon Mejifuijitsukusu Kk 診断用造影剤
EP1106186A2 (en) * 1999-12-08 2001-06-13 Mallinckrodt Inc. Non-covalent bioconjugates useful for magnetic resonance imaging
JP2002512942A (ja) * 1998-04-28 2002-05-08 ヤーゴウテック アーゲー ヒアルロナン系像形成剤
WO2002040060A2 (en) * 2000-10-31 2002-05-23 Bracco International Bv Conjugates of an antioxidants with metal chelating ligands
WO2002043775A2 (en) * 2000-11-20 2002-06-06 GODFREY, Cullen, M. Paramagnetic metal ion-based macrocyclic contrast agents
WO2003013617A2 (de) * 2001-07-20 2003-02-20 Schering Ag Konjugate makrocyclischer metallkomplex mit biomolekülen und deren verwendung zur herstellung von mitteln für die nmr- und radiodiagnostik sowie die radiotherapie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
US5050609B1 (en) 1987-10-04 1999-11-02 Us Health Magnetization transfer contrast and proton relaxation and use thereof in magnetic resonance imaging
JPH04501723A (ja) * 1988-11-09 1992-03-26 アンガー，エヴァン，シー． リポソーム性放射線造影剤
JP2774378B2 (ja) * 1991-02-08 1998-07-09 ダイアテク，インコーポレイテッド 映像用テクネチウム−９９ｍ標識化ポリペプチド
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
US5707605A (en) * 1995-06-02 1998-01-13 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
EP1178837A2 (en) * 1999-04-21 2002-02-13 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method for enhancing contrast produced by mri
EP1331012A1 (en) * 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Responsive paramagnetic MRI contrast agents

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0597712A (ja) * 1991-10-04 1993-04-20 Nippon Mejifuijitsukusu Kk 診断用造影剤
JP2002512942A (ja) * 1998-04-28 2002-05-08 ヤーゴウテック アーゲー ヒアルロナン系像形成剤
EP1106186A2 (en) * 1999-12-08 2001-06-13 Mallinckrodt Inc. Non-covalent bioconjugates useful for magnetic resonance imaging
WO2002040060A2 (en) * 2000-10-31 2002-05-23 Bracco International Bv Conjugates of an antioxidants with metal chelating ligands
WO2002043775A2 (en) * 2000-11-20 2002-06-06 GODFREY, Cullen, M. Paramagnetic metal ion-based macrocyclic contrast agents
WO2003013617A2 (de) * 2001-07-20 2003-02-20 Schering Ag Konjugate makrocyclischer metallkomplex mit biomolekülen und deren verwendung zur herstellung von mitteln für die nmr- und radiodiagnostik sowie die radiotherapie

Also Published As

Publication number Publication date
EP2116267A1 (en) 2009-11-11
EP1466629A1 (en) 2004-10-13
US20070036727A1 (en) 2007-02-15
WO2004089424A1 (en) 2004-10-21
EP1613358A1 (en) 2006-01-11
AU2004228932A1 (en) 2004-10-21
DE602004023492D1 (de) 2009-11-19
AU2004228932B2 (en) 2009-11-05
ZA200508155B (en) 2007-01-31
EP1613358B1 (en) 2009-10-07
AU2004228932A2 (en) 2004-10-21
CN100579583C (zh) 2010-01-13
US8945512B2 (en) 2015-02-03
CN1809386A (zh) 2006-07-26
JP2006522761A (ja) 2006-10-05
ATE444763T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
Jacques et al. New classes of MRI contrast agents
US6232295B1 (en) Cell-specific contrast agent and gene delivery vehicles
Rudovský et al. PAMAM dendrimeric conjugates with a Gd− DOTA phosphinate derivative and their adducts with polyaminoacids: the interplay of global motion, internal rotation, and fast water exchange
RU2305096C2 (ru) Соединение, способ его получения
Lebdušková et al. A gadolinium (III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent
US20070014725A1 (en) Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy
Nwe et al. Comparison of MRI properties between derivatized DTPA and DOTA gadolinium–dendrimer conjugates
Nwe et al. Poly (amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques
JP2007008954A (ja) ペプチド凝集体
JP4891763B2 (ja) 「ｃｅｓｔ」用途のための、磁気共鳴シフト試薬と交換性プロトンを含有する基質との付加物
Nwe et al. A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives
US10201622B2 (en) Tumour-targeted theranostic
Rashid et al. Lanthanide (III) chelates as MRI contrast agents: a brief description
Ndiaye et al. Comparison of MRI properties between multimeric DOTAGA and DO3A Gadolinium-Dendron conjugates
Lee et al. One step synthesis of quantum dot–magnetic nanoparticle heterodimers for dual modal imaging applications
Nwe et al. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI
Pushparaj et al. Trinuclear Gd (III) metal complex with amide core display remarkable enhancement in relaxivity
CA2201750A1 (en) Chelate complex with high conspicuity for magnetic resonance imaging
Pushparaj et al. Novel Designing of Ir (III)(Tris-Coumarin) Cored Gd (III) Complex as Targeted MRI CAs for Ovarian Cancer Treatment
US8784778B2 (en) MRI contrast agents endowed with concentration independent responsiveness
EP1106186A2 (en) Non-covalent bioconjugates useful for magnetic resonance imaging
Angelovski Magnetic Resonance Imaging Bio-Sensors for Calcium (II)
Henoumont et al. Characterization of Organic Molecules Grafted to Silica or Bismuth Nanoparticles by NMR. Appl. Nano 2021, 2, 330–343
D. Moore et al. Multilanthanide systems for medical imaging applications
CN121197448A (zh) 核磁荧光双模态成像探针及其制备方法与应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070330

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070330

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100525

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100823

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100830

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100924

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101001

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101025

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110301

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110519

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110526

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110630

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110707

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110729

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110831

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111122

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111216

R150 Certificate of patent or registration of utility model

Ref document number: 4891763

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141222

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees